ES2108350T3 - Procedimiento para la preparacion de 5-arilhidantoinas. - Google Patents

Procedimiento para la preparacion de 5-arilhidantoinas.

Info

Publication number
ES2108350T3
ES2108350T3 ES94115663T ES94115663T ES2108350T3 ES 2108350 T3 ES2108350 T3 ES 2108350T3 ES 94115663 T ES94115663 T ES 94115663T ES 94115663 T ES94115663 T ES 94115663T ES 2108350 T3 ES2108350 T3 ES 2108350T3
Authority
ES
Spain
Prior art keywords
compound
preparation
instituted
arilhidantoinas
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94115663T
Other languages
English (en)
Inventor
Hiroshi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Application granted granted Critical
Publication of ES2108350T3 publication Critical patent/ES2108350T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SUMINISTRA UN NUEVO PROCESO PARA LA PREPARACION DE 5ARILOHIDANTOINAS COMO PRODUCTO INTERMEDIO IMPORTANTE DE LAS (D)ARILGLICINAS (POR EJEMPLO (D)-P-HIDROXIFENILGLICINAS) UTILES PARA LA SINTESIS DE PENICILINAS Y CEFALOSPORINAS SEMISINTETICAS, EL PROCESO COMPRENDE I) LA REACCION DE UN COMPUESTO DE HIDANTOINA 5-INSUSTITUIDO CON UN AGENTE HALOGENANTE Y II) LA REACCION DEL PRODUCTO RESULTANTE CON UN COMPUESTO DE FENOL P-INSUSTITUIDO, EL GRUPO DE HIDROXIDO DEL CUAL PUEDE ESTAR PROTEGIDO, PARA SUSTITUIR LA POSICION 5 DEL COMPUESTO DE HIDANTOINA CON EL COMPUESTO DE FENOL EN LA POSICION PARA.
ES94115663T 1993-10-06 1994-10-05 Procedimiento para la preparacion de 5-arilhidantoinas. Expired - Lifetime ES2108350T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25076993 1993-10-06
JP25077093 1993-10-06

Publications (1)

Publication Number Publication Date
ES2108350T3 true ES2108350T3 (es) 1997-12-16

Family

ID=26539914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94115663T Expired - Lifetime ES2108350T3 (es) 1993-10-06 1994-10-05 Procedimiento para la preparacion de 5-arilhidantoinas.

Country Status (3)

Country Link
EP (1) EP0647630B1 (es)
DE (1) DE69405671T2 (es)
ES (1) ES2108350T3 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001319A1 (en) * 1977-08-18 1979-04-04 Beecham Group Plc Process for the preparation of hydroxyphenyl hydantoin and of hydroxyphenyl glycine, and compounds thus obtained

Also Published As

Publication number Publication date
EP0647630A1 (en) 1995-04-12
DE69405671T2 (de) 1998-02-12
EP0647630B1 (en) 1997-09-17
DE69405671D1 (de) 1997-10-23

Similar Documents

Publication Publication Date Title
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
BR0213355A (pt) composições farmacêuticas
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
ES2108228T3 (es) Factor de diferenciacion de megacariocitos.
ECSP024400A (es) Derivados de pleuromutilina que tiene actividad antibacteriana
MXPA01008346A (es) Compuestos quimicos.
PA8448601A1 (es) Producto alimenticio congelado
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
PY990129A (es) Bromhidrato de eletriptan monohidratado
ES2057341T3 (es) Ciclohexenos substituidos como agentes para el sistema nervioso central.
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
UY26494A1 (es) " estabilización de vino"
GB9828020D0 (en) Synthesis of heteropolyacids
PT1091970E (pt) Processo para a preparacao de aloina por extraccao
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
ES2068412T3 (es) Procedimiento para la obtencion de 2-(3-aminopropil)-cicloalquil-aminas.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
ES2125309T3 (es) Derivados de tiomarinol y procedimientos para su preparacion.
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
ECSP941053A (es) Proceso quimico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 647630

Country of ref document: ES